全身PET/CT在炎症性疾病中的作用
本综述探讨长轴视野(LAFOV)PET/CT扫描仪在炎症性疾病成像中的作用与优势。LAFOV PET/CT可单床位同时成像大部分人体,信号采集效率优于常规PET,支持更短采集时间、更低注射剂量、更长摄取时间或这些的组合,并实现全身动态成像,从而在局部和全身性疾病评估中发挥越来越重要的作用。
要点
- LAFOV PET/CT可单床位同时成像大部分人体,信号采集效率优于常规PET扫描仪。
- LAFOV PET/CT支持更短采集时间、更低注射剂量、更长摄取时间或这些的组合。
- LAFOV PET/CT可实现全身动态成像,在局部和全身性疾病评估中贡献日益显著。
核心结论
- LAFOV PET/CT扫描仪的内在优越能力使其在炎症性疾病评估中贡献日益显著,本综述旨在进一步探讨其作用与优势并讨论未来发展与挑战。
研究设计与样本
- 本综述探讨长轴视野(LAFOV)PET/CT扫描仪在炎症性疾病成像中的作用与益处。
主要发现
- 炎症性疾病传统上难以用常规PET成像监测,限制包括辐射暴露、缺乏经验证的成像生物标志物、低空间分辨率和长采集时间。
- LAFOV PET扫描仪可单床位同时成像大部分人体(若非全身),信号采集效率较常规PET扫描仪提高。
- LAFOV PET允许更短采集时间、更低注射放射性示踪剂剂量、更长摄取时间或这些的组合。
- LAFOV PET扫描仪可实现全身动态成像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inflammatory disorders historically have been difficult to monitor with conventional PET imaging due to limitations including radiation exposure, lack of validated imaging biomarkers, low spatial resolution, and long acquisition durations. However, the recent development of long-axial field-of-view (LAFOV) PET/CT scanners may allow utilization of novel noninvasive biomarkers to diagnose, predict outcomes, and monitor therapeutic response of inflammatory conditions. LAFOV PET scanners can image most of the human body (if not the entire body) simultaneously in one bed position, with improved signal collection efficiency compared to conventional PET scanners. This allows for imaging with shorter acquisition durations, decreased injected radiotracer dose, prolonged uptake times, or a combination of any of these. In addition, LAFOV PET scanners enable whole-body dynamic imaging. Altogether, these intrinsically superior capabilities in assessing both local and systemic diseases, have allowed these scanners to make increasingly significant contributions to the assessment of inflammatory conditions. This review aims to further explore the role and benefits of LAFOV scanners for imaging various inflammatory conditions while addressing future developments and challenges faced by this technology.
引用
- Zoghi S, Mingels C, Badawi RD, et al. Role of Total Body PET/CT in Inflammatory Disorders. Semin Nucl Med. 2024. PMID: 39578110. doi:10.1053/j.semnuclmed.2024.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。